Joelle B.
- Country
- France
- Department
- N/A
Research Overview
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study
- Evaluation of EXL01 for the Prevention of Post-Operative Recurrence in Crohn's Disease: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 87 of 304 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating complex inflammatory bowel diseases, with particular emphasis on Crohn's Disease and Ulcerative Colitis.
- Moderate to Severe Disease States
- Novel Therapeutic Approaches
- Long-term Disease Management
The research focus encompasses innovative treatments for patients with challenging inflammatory conditions.
Clinical Remission Studies
Expertise in evaluating endoscopic improvement and achieving symptomatic remission in inflammatory bowel conditions.
- Endoscopic Response Assessment
- Clinical Remission Markers
- Treatment Response Evaluation
The investigator focuses on developing effective therapeutic strategies for achieving sustainable disease control.
Therapeutic Innovation
Specialized in investigating novel biological therapies and evaluating emerging treatment options for inflammatory bowel conditions.
- Induction Therapy Assessment
- Long-term Safety Monitoring
- Treatment Optimization Studies
Research activities concentrate on advancing therapeutic options for patients with treatment-resistant conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.